Z-1864-2017 Class II Terminated
FDA device recall Z-1864-2017 was initiated by BD LIFE SCIENCES on July 29, 2015 and is designated Class II. Reason for recall: The BD MAX System software version 4.44A contains a software anomaly that has the potential to affect some Open System Reagent (OSR) customers utilizing User Defined Protocol (UDP) assays. Customers u… The recall status is terminated (terminated April 19, 2017). Affected quantity: There are 29 US customers and 5 ex-US regions with a BD MAX System running software version 4.44A..
Recall Details
- Product Type
- Devices
- Report Date
- April 26, 2017
- Initiation Date
- July 29, 2015
- Termination Date
- April 19, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- There are 29 US customers and 5 ex-US regions with a BD MAX System running software version 4.44A.
Product Description
Reason for Recall
Distribution Pattern
Worldwide Distribution - US Distribution to the states of : CA, CO, FL, IL, MN, MO, MT, NE, NJ, NY, OH, OR, PA, TX, TN, WA, WI., and to the countries of : Canada, Hong Kong, Taiwan, Turkey and Europe. Federal Government Agency sales/distribution centers or foreign countries VA Fort Harrison and VAMC Austin.